These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35259555)

  • 21. Emergent Carotid Stenting Plus Thrombectomy After Thrombolysis in Tandem Strokes: Analysis of the TITAN Registry.
    Anadani M; Spiotta AM; Alawieh A; Turjman F; Piotin M; Haussen DC; Nogueira RG; Papanagiotou P; Siddiqui AH; Lapergue B; Dorn F; Cognard C; Ribo M; Psychogios MN; Labeyrie MA; Mazighi M; Biondi A; Anxionnat R; Bracard S; Richard S; Gory B;
    Stroke; 2019 Aug; 50(8):2250–2252. PubMed ID: 31577899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT.
    Zonneveld TP; Algra A; Dippel DW; Kappelle LJ; van Oostenbrugge RJ; Roos YB; Wermer MJ; van der Worp HB; Nederkoorn PJ; Kruyt ND;
    BMC Neurol; 2015 Nov; 15():241. PubMed ID: 26596237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral edema in acute ischemic stroke patients treated with intravenous thrombolysis.
    Strbian D; Meretoja A; Putaala J; Kaste M; Tatlisumak T;
    Int J Stroke; 2013 Oct; 8(7):529-34. PubMed ID: 22405327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.
    Song HY; Chung JI; Jalin AMA; Ju C; Pahk K; Joung C; Lee S; Jin S; Kim BS; Lee KS; Ryu JM; Kim WK
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodinated Contrast Agents Reduce the Efficacy of Intravenous Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients: a Multicenter Cohort Study.
    Chen Z; Xu C; Zhong W; Gong X; Hu H; Zhang X; Chen Y; Li Q; Luo Z; Chen Z; Lou M
    Transl Stroke Res; 2021 Aug; 12(4):530-539. PubMed ID: 32895894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors for Cerebral Edema in Acute Ischemic Stroke Treated With Intravenous Thrombolysis.
    Thorén M; Azevedo E; Dawson J; Egido JA; Falcou A; Ford GA; Holmin S; Mikulik R; Ollikainen J; Wahlgren N; Ahmed N
    Stroke; 2017 Sep; 48(9):2464-2471. PubMed ID: 28775140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does renal dysfunction modify the effect of intravenous thrombolysis for acute ischemic stroke within 4.5 hours of onset? A multicenter observational study.
    Hsieh CY; Lin HJ; Sung SF; Yang YH; Lai EC; Hsieh HC; Chen CH
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):673-9. PubMed ID: 25577428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post rtPA CT brain may not be mandatory in all stroke patients when resources are limited.
    Dharmasaroja PA; Muengtaweepongsa S; Dharmasaroja P
    Clin Neurol Neurosurg; 2013 Mar; 115(3):285-8. PubMed ID: 22749008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 2-point difference of NIHSS as a predictor of acute ischemic stroke outcome at 3 months after thrombolytic therapy.
    Jantasri S; Tiamkao S; Sawanyawisuth K
    Clin Neurol Neurosurg; 2020 Nov; 198():106206. PubMed ID: 32932029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of a "drip and ship" intravenous thrombolysis protocol for patients with acute ischemic stroke.
    Mansoor S; Zand R; Al-Wafai A; Wahba MN; Giraldo EA
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):969-71. PubMed ID: 22306381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Outcome of Decompressive Hemicraniectomy After Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke: A Systematic Review.
    Pedro KM; Roberto KT; Chua AE
    World Neurosurg; 2020 Dec; 144():50-58. PubMed ID: 32822948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic thrombolysis in ischaemic stroke patients with COVID-19.
    Sobolewski P; Antecki J; Brola W; Fudala M; Bieniaszewski L; Kozera G
    Acta Neurol Scand; 2022 Jan; 145(1):47-52. PubMed ID: 34415051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy.
    Sanders CB; Knisely K; Rathfoot C; Edrissi C; Nathaniel T
    Clin Appl Thromb Hemost; 2022; 28():10760296221116347. PubMed ID: 36278505
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety and efficacy of antiplatelet use before intravenous thrombolysis for acute Ischemic stroke.
    Mowla A; Sharifian-Dorche M; Mehla S; Lail NS; Sharifian-Dorche A; Vaughn CB; Sawyer RN; Shirani P
    J Neurol Sci; 2021 Jun; 425():117451. PubMed ID: 33882341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?
    Agarwal P; Kumar S; Hariharan S; Eshkar N; Verro P; Cohen B; Sen S
    Cerebrovasc Dis; 2004; 17(2-3):182-90. PubMed ID: 14707420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intravenous thrombolytic therapy with Revelisa of ischemic stroke in real-world clinical practice: interim results of an open-label, prospective, multicenter, non-interventional study IVT-AIS-R].
    Soldatov MA; Marskaya NA; Barsegova KA; Androfagina OV; Borisov DN; Karpov DY; Kishinevsky MV; Kucheryavaya MV; Tabakman SV; Telyatnik YA; Fadeeva AS; Khan DS; Chirkov AN; Shamalov NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3. Vyp. 2):33-37. PubMed ID: 33908230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy.
    Inohara T; Liang L; Kosinski AS; Smith EE; Schwamm LH; Hernandez AF; Bhatt DL; Fonarow GC; Peterson ED; Xian Y
    J Am Heart Assoc; 2019 Aug; 8(15):e012450. PubMed ID: 31327296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombolytic therapy in acute ischemic stroke in Asia: The first prospective evaluation.
    Suwanwela NC; Phanthumchinda K; Likitjaroen Y
    Clin Neurol Neurosurg; 2006 Sep; 108(6):549-52. PubMed ID: 16289309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C; Bai Q; Zhao Z; Zhang J
    Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II).
    Larrue V; von Kummer R R; Müller A; Bluhmki E
    Stroke; 2001 Feb; 32(2):438-41. PubMed ID: 11157179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.